Ligand · IOG
IOG · N-[(1R)-3-(4-hydroxyphenyl)-1-methylpropyl]-2-[2-phenyl-6-(2-piperidin-1-ylethoxy)-1H-indol-3-yl]acetamide
IOG, N-[(1R)-3-(4-hydroxyphenyl)-1-methylpropyl]-2-[2-phenyl-6-(2-piperidin-1-ylethoxy)-1H-indol-3-yl]acetamide (C33 H39 N3 O3, 525.7 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with…
- Component
- IOG
- Formula
- C33 H39 N3 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
IOG in 2 structures; the first of them:
- 2IOG · Human estrogen receptor alpha ligand-binding domain in complex with compound 11F · IOG A600 · binds LEU346, THR347, LEU349, ALA350, ASP351, GLU353, LEU354, TRP383 and 20 more
- 2IOG · Human estrogen receptor alpha ligand-binding domain in complex with compound 11F · IOG A600 · binds LEU346, THR347, LEU349, ALA350, ASP351, GLU353, LEU354, TRP383 and 20 more
Residues it binds most
LEU 2, MET 2, GLU 2, GLY 2, PHE 2, ALA 2, ARG 2, ASP 2, CYS 2, HIS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.